平安健康App上线“原研药专区” 用户可根据医生建议直接购买

Ping An Health App has launched a branded drug section, offering convenient medication purchasing services that allow users to quickly obtain the drugs they need.

1. It introduces 166 branded drugs, covering 92% of the varieties available online, spanning approximately 70 types across 15 major medical departments to meet the demand for high-quality medications.

2. The purchasing process is simple: users can access the section via the Health Pharmacy in the Ping An Health App or the Chinese & Western Medicine section in the Haofuli App to directly select and purchase medications.

3. Doctors can recommend branded drugs based on the patient's condition and place orders directly, seamlessly connecting diagnosis and treatment with purchasing, enabling users to complete the entire process from consultation to medication acquisition without leaving home.

4. Services include 24/7 online consultations and a "price-match guarantee" for over 300 common medications, improving efficiency and shortening the medication procurement process.

Ping An Health demonstrates brand marketing and channel innovation through its branded drug section, responding to consumer trends.

1. Brand Marketing: The section meets user demand for high-quality medications, enhancing brand image, while utilizing big data and AI for personalized recommendations.

2. Channel Development: Leveraging dual App platforms for direct sales expands coverage, with partnerships involving 233,000 pharmacies to strengthen channel penetration.

3. Product Strategy: Introducing branded drugs as innovative products addresses diverse medical needs across multiple departments, aligning with trends for convenience and variety.

4. User Behavior Insights: Simplified online purchasing behaviors and the doctor-recommended ordering model reflect user preferences for efficient services.

The branded drug section highlights growth markets and emerging business models, offering learnable opportunities.

1. Growth Market: Covering 92% of online branded drug varieties, it taps into unmet user needs, indicating expansion potential in the online health market.

2. Evolving Consumer Demand: Increasing user preference for convenient purchasing and high-quality medications, such as seamless diagnosis-to-purchase services completed entirely online.

3. Emerging Business Models: The integrated online diagnosis and medication purchasing model shortens processes; sellers can learn from Ping An Health's "Three-Reach" service network development.

4. Collaboration Models: Partnerships with over 50,000 doctors providing recommendation services offer avenues for sellers to explore similar collaborations to enhance sales efficiency.

5. Learnable Insights: Application of big data, AI, and blockchain for transparent drug traceability provides examples for sellers to adopt in optimizing risk management.

The section offers insights into product production and digitalization, revealing commercial opportunities.

1. Production Requirements: Branded drugs require rigorous clinical trials and high-quality control, presenting opportunities for factories to supply such innovative medications.

2. Commercial Opportunities: Ping An Health's introduction of 166 branded drugs across broad categories opens pathways for factories to explore supplier partnerships.

3. Digitalization Insights: Sales through App platforms and blockchain-enabled transparent circulation suggest strategies for factories to integrate e-commerce and improve production responsiveness.

4. Case Study Example: The platform's coverage of 92% of online varieties demonstrates how digitalization addresses limited channel issues, offering models for factories to optimize supply chains.

The section highlights industry trends and new technology solutions addressing client pain points.

1. Industry Trends: Expansion of online health services, such as the branded drug section covering multi-department medications, indicates a direction toward e-commerce integration.

2. Technology Applications: Use of big data and AI for precise demand analysis and personalized recommendations; blockchain ensures transparent and traceable drug circulation.

3. Client Pain Points: Limited access channels for branded drugs are addressed through one-stop solutions that shorten the purchasing process.

4. Solutions: The seamless doctor-recommended ordering model integrates diagnosis and treatment; service providers can learn from Ping An Health's "Three-Reach" network (online consultations, home delivery, store partnerships) to enhance service efficiency.

The section showcases the platform's latest practices and operational management in response to user demands.

1. Latest Platform Initiatives: Launch of the branded drug section integrates 166 medications, covering 92% of online varieties, with convenient services via dual App platforms.

2. Operational Management: Development of the "Three-Reach" service network, including 24/7 online consultations, home medication guarantees, and partnerships with 4,000 hospitals, ensuring nationwide coverage.

3. Responding to Commercial Demands: High user demand for efficient medication procurement is met through the doctor-recommended direct ordering model, solving seamless integration challenges.

4. Risk Mitigation: Use of blockchain technology ensures circulation security, reducing risks; platforms can adopt similar practices to enhance operational robustness.

The section reflects industry developments and business models, offering policy implications.

1. Industry Trends: Innovations in online health platforms, such as the branded drug section covering multi-department varieties, address limited access channels.

2. Emerging Issues: Unmet user needs after branded drugs exit the market are explored through seamless diagnosis models as potential solutions.

3. Business Model Analysis: Ping An Health's "Three-Reach" service network enables full-course disease management, providing a case for researchers to evaluate its effectiveness.

4. Policy Implications: Technologies like blockchain for drug traceability may influence regulatory frameworks, suggesting avenues for researchers to explore transparency recommendations.